miR-193b promotes cell proliferation by targeting Smad3 in human glioma

Journal of Neuroscience Research

Volumn 92, Issue 5, 2014, Pages 619-626

  Zhong, Qisheng ^a   Wang, Tongli ^a   Lu, Peigang ^a   Zhang, Rongwei ^a   Zou, Jianan ^a   Yuan, Shaoji ^a  

^a JINAN MILITARY GENERAL HOSPITAL   (China)

Author keywords

Cell proliferation; Glioma; MiR 193b; P21; Smad3

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 193B; PROTEIN P21; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL CYCLE ARREST; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

CELL PROLIFERATION; GLIOMA; MIR-193B; P21; SMAD3;

ADULT; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HEK293 CELLS; HUMANS; MALE; MICRORNAS; OLIGONUCLEOTIDES; RNA, SMALL INTERFERING; SINCALIDE; SMAD3 PROTEIN; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; YOUNG ADULT;

EID: 84895930986     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23339     Document Type: Article

References (35)

1. Alizadeh AA, Eisen MB, Davis RE, et al. 2000. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511.
2. Ambros V. 2004. The functions of animal microRNAs. Nature 431:350-355.
3. Andersson A, Ritz C, Lindgren D, et al. 2007. Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status. Leukemia 21:1198-1203.
4. Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297.
5. Calin GA, Croce CM. 2006. MicroRNA signatures in human cancers. Nat Rev Cancer 6:857-866.
6. Cimmino A, Calin GA, Fabbri M, et al. 2005. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 102:13944-13949.
7. Daly AC, Vizan P, Hill CS. 2010. Smad3 protein levels are modulated by Ras activity and during the cell cycle to dictate transforming growth factor-beta responses. J Biol Chem 285:6489-6497.
8. Epstein FH, Blobe GC, Schiemann WP, Lodish HF. 2000. Role of transforming growth factor β in human disease. N Engl J Med 342:1350-1358.
9. Esquela-Kerscher A, Slack FJ. 2006. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6:259-269.
10. Gao XN, Lin J, Gao L, Li YH, Wang LL, Yu L. 2011. MicroRNA-193b regulates c-Kit proto-oncogene and represses cell proliferation in acute myeloid leukemia. Leuk Res 35:1226-1232.
11. Grimson A, Farh KK-H, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. 2007. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27:91-105.
12. Han SU, Kim HT, Seong DH, et al. 2004. Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer. Oncogene 23:1333-1341.
13. Helwak A, Kudla G, Dudnakova T, Tollervey D. 2013. Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 153:654-665.
14. Hendrix ND, Wu R, Kuick R, Schwartz DR, Fearon ER, Cho KR. 2006. Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas. Cancer Res 66:1354-1362.
15. Jeruss JS, Sturgis CD, Rademaker AW, Woodruff TK. 2003. Down-regulation of activin, activin receptors, and Smads in high-grade breast cancer. Cancer Res 63:3783-3790.
16. Johnson DR, O'Neill BP. 2012. Glioblastoma survival in the United States before and during the temozolomide era. J Neurooncol 107:359-364.
17. Johnson SM, Grosshans H, Shingara J, et al. 2005. RAS is regulated by the let-7 microRNA family. Cell 120:635-647.
18. Lancaster JM, Dressman HK, Whitaker RS, et al. 2004. Gene expression patterns that characterize advanced stage serous ovarian cancers. J Soc Gynecol Invest 11:51-59.
19. Lapointe J, Li C, Higgins JP, et al. 2004. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci U S A 101:811-816.
20. Lenarduzzi M, Hui ABY, Alajez NM, et al. 2013. MicroRNA-193b enhances tumor progression via down regulation of neurofibromin 1. PLoS One 8:e53765.
21. Li XF, Yan PJ, Shao ZM. 2009. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer. Oncogene 28:3937-3948.
22. Mendell JT. 2008. miRiad roles for the miR-17-92 cluster in development and disease. Cell 133:217-222.
23. Nass D, Rosenwald S, Meiri E, et al. 2009. MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathol 19:375-383.
24. Purow B, Schiff D. 2009. Advances in the genetics of glioblastoma: are we reaching critical mass? Nat Rev Neurol 5:419-426.
25. Rauhala HE, Jalava SE, Isotalo J, et al. 2010. miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer. Int J Cancer 127:1363-1372.
26. Shkumatava A, Stark A, Sive H, Bartel DP. 2009. Coherent but overlapping expression of microRNAs and their targets during vertebrate development. Genes Dev 23:466-481.
27. Unno K, Zhou Y, Zimmerman T, Platanias LC, Wickrema A. 2009. Identification of a novel microRNA cluster miR-193b-365 in multiple myeloma. Leuk Lymphoma 50:1865-1871.
28. Wick W, Naumann U, Weller M. 2006. Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma. Curr Pharm Des 12:341-349.
29. Wolfraim LA, Fernandez TM, Mamura M, et al. 2004. Loss of Smad3 in acute T-cell lymphoblastic leukemia. N Engl J Med 351:552-559.
30. Worley LA, Long MD, Onken MD, Harbour JW. 2008. Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling. Melanoma Res 18:184-190.
31. Xiong Y, Fang JH, Yun JP, et al. 2010. Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology 51:836-845.
32. Yang X, Liang L, Zhang X, et al. 2013. MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway. Hepatology 58:158-170.
33. Yoon Ar, Gao R, Kaul Z, et al. 2011. MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3′ untranslated region. Nucleic Acids Res 39:8078-8091.
34. Yu YP, Landsittel D, Jing L, et al. 2004. Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol 22:2790-2799.
35. Zhang L, Sato E, Amagasaki K, Nakao A, Naganuma H. 2006. Participation of an abnormality in the transforming growth factor-beta signaling pathway in resistance of malignant glioma cells to growth inhibition induced by that factor. J Neurosurg 105:119-128.